Horizon Space Acquisition II Corp. Units Cons of 1 Shs + 1 Rts HSPTU 深 沪
已收盘 01-30 16:00:00 美东时间
10.21
-0.680
-6.24%
华盛通- 最 高10.90
- 今 开10.90
- 成交量 2953股
- 最 低 10.01
- 昨 收 10.89
- 总市值 6330.20万
- 52周最高 10.90
- 市盈率 静 650.32
- 换手率 0.05%
- 52周最低 10.01
- 委 比 0.00%
- 总股本 620.00万
- 历史最高 10.90
- 量 比 3.98
- 振 幅 8.17%
- 历史最低 9.98
- 每 手 1
- 风险率 0.17%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Horizon Space Acquisition I Corp. Issues $500,000 Unsecured Promissory Note to Sponsor
Horizon Space Acquisition I Corp. Issues $500,000 Unsecured Promissory Note to Sponsor Horizon Space Acquisition I Corp. has entered into a new financing agreement with its sponsor, Horizon Space Acquisition I Sponsor Corp. On January 26, 2026, the company issued an unsecured promissory note for a p
01-28 05:54
SPAC Merger To Take SL Bio Public Through New Entity In 2026
SL Bio files Form F-4 with SEC to merge with Horizon Space Acquisition II Corp. Valued at $5.7B, SL Science Holding Limited will be listed as SLBT on NASDAQ. Alternative listing path for science-driven companies. Expected public listing in early 2026.
01-09 23:41
Horizon Space Acquisition II Corp. Issues Promissory Note
Horizon Space Acquisition II Corp. ( ($HSPT) ) has issued an update. On July 5,...
2025-07-08 21:28
Horizon Space Extends Merger Deadline to July 2025
Horizon Space Acquisition I Corporation ( ($HSPO) ) has provided an announcemen...
2025-07-01 02:54
Horizon Space Acquisition I Corp. Issues Promissory Note
An announcement from Horizon Space Acquisition I Corporation ( ($HSPO) ) is now...
2025-06-14 04:55
Horizon Space Acquisition II announces business combination agreement with SL Bio
Horizon Space Acquisition II Corp. (NASDAQ:HSPT), a publicly traded special purpose acquisition company, and SL Bio, a clinical-stage biomedical company specialized in developing groundbreaking cellul...
2025-05-12 20:54
